Cargando…
Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649384/ http://dx.doi.org/10.1186/2051-1426-3-S2-P201 |
| _version_ | 1782401346765324288 |
|---|---|
| author | de Gruijl, Tanja D Koster, Bas D van den Hout, Mari FCM Sluijter, Berbel JR Molenkamp, Barbara G Vuylsteke, Ronald JCLM van Leeuwen, Paul AM Scheper, Rik J van den Tol, Petrousjka van den Eertwegh, Alfons |
| author_facet | de Gruijl, Tanja D Koster, Bas D van den Hout, Mari FCM Sluijter, Berbel JR Molenkamp, Barbara G Vuylsteke, Ronald JCLM van Leeuwen, Paul AM Scheper, Rik J van den Tol, Petrousjka van den Eertwegh, Alfons |
| author_sort | de Gruijl, Tanja D |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649384 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46493842015-11-24 Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials de Gruijl, Tanja D Koster, Bas D van den Hout, Mari FCM Sluijter, Berbel JR Molenkamp, Barbara G Vuylsteke, Ronald JCLM van Leeuwen, Paul AM Scheper, Rik J van den Tol, Petrousjka van den Eertwegh, Alfons J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649384/ http://dx.doi.org/10.1186/2051-1426-3-S2-P201 Text en Copyright © 2015 de Gruijl et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation de Gruijl, Tanja D Koster, Bas D van den Hout, Mari FCM Sluijter, Berbel JR Molenkamp, Barbara G Vuylsteke, Ronald JCLM van Leeuwen, Paul AM Scheper, Rik J van den Tol, Petrousjka van den Eertwegh, Alfons Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials |
| title | Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials |
| title_full | Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials |
| title_fullStr | Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials |
| title_full_unstemmed | Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials |
| title_short | Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials |
| title_sort | adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose cpg-b and gm-csf increases recurrence-free survival: long-term follow-up of three randomized clinical trials |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649384/ http://dx.doi.org/10.1186/2051-1426-3-S2-P201 |
| work_keys_str_mv | AT degruijltanjad adjuvanttreatmentofearlystagemelanomabylocalidadministrationoflowdosecpgbandgmcsfincreasesrecurrencefreesurvivallongtermfollowupofthreerandomizedclinicaltrials AT kosterbasd adjuvanttreatmentofearlystagemelanomabylocalidadministrationoflowdosecpgbandgmcsfincreasesrecurrencefreesurvivallongtermfollowupofthreerandomizedclinicaltrials AT vandenhoutmarifcm adjuvanttreatmentofearlystagemelanomabylocalidadministrationoflowdosecpgbandgmcsfincreasesrecurrencefreesurvivallongtermfollowupofthreerandomizedclinicaltrials AT sluijterberbeljr adjuvanttreatmentofearlystagemelanomabylocalidadministrationoflowdosecpgbandgmcsfincreasesrecurrencefreesurvivallongtermfollowupofthreerandomizedclinicaltrials AT molenkampbarbarag adjuvanttreatmentofearlystagemelanomabylocalidadministrationoflowdosecpgbandgmcsfincreasesrecurrencefreesurvivallongtermfollowupofthreerandomizedclinicaltrials AT vuylstekeronaldjclm adjuvanttreatmentofearlystagemelanomabylocalidadministrationoflowdosecpgbandgmcsfincreasesrecurrencefreesurvivallongtermfollowupofthreerandomizedclinicaltrials AT vanleeuwenpaulam adjuvanttreatmentofearlystagemelanomabylocalidadministrationoflowdosecpgbandgmcsfincreasesrecurrencefreesurvivallongtermfollowupofthreerandomizedclinicaltrials AT scheperrikj adjuvanttreatmentofearlystagemelanomabylocalidadministrationoflowdosecpgbandgmcsfincreasesrecurrencefreesurvivallongtermfollowupofthreerandomizedclinicaltrials AT vandentolpetrousjka adjuvanttreatmentofearlystagemelanomabylocalidadministrationoflowdosecpgbandgmcsfincreasesrecurrencefreesurvivallongtermfollowupofthreerandomizedclinicaltrials AT vandeneertweghalfons adjuvanttreatmentofearlystagemelanomabylocalidadministrationoflowdosecpgbandgmcsfincreasesrecurrencefreesurvivallongtermfollowupofthreerandomizedclinicaltrials |